SYNAGEVA BIOPHARMA CORP 3
3 · SYNAGEVA BIOPHARMA CORP · Filed Jun 29, 2015
Insider Transaction Report
Form 3
ALEXION PHARMACEUTICALS INC
10% Owner
Holdings
- 21,021,124(indirect: Through direct, wholly owned subsidiary (see explanatory note))
Common stock, par value $0.001 per share, of Synageva